Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 311

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

291	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	01/29/2014 1:13:59 PM
290	$NVLX Nuvilex Ahead of the Curve on	stocklegend	01/29/2014 12:51:13 PM
289	$NVLX Investors Confidently Back Nuvilex's	stocklegend	01/29/2014 11:56:37 AM
288	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	01/29/2014 11:36:42 AM
287	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	01/29/2014 10:37:17 AM
286	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	01/29/2014 10:01:23 AM
285	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	01/29/2014 9:37:53 AM
284	$NVLX Nuvilex Begins Making Moves at its	stocklegend	01/29/2014 9:14:26 AM
283	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	01/29/2014 8:46:56 AM
282	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	01/28/2014 3:39:00 PM
281	$NVLX Nuvilex COO Talks About Companys	stocklegend	01/28/2014 3:20:27 PM
280	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	01/28/2014 2:22:54 PM
279	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	01/28/2014 1:38:34 PM
278	$NVLX - Nuvilex COO Talks Medical Marijuana in NY	stocklegend	01/28/2014 12:15:23 PM
277	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	01/28/2014 11:36:48 AM
276	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	01/28/2014 11:05:41 AM
275	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	01/28/2014 10:19:28 AM
274	$NVLX - Nuvilex Restructures its Operations to	stocklegend	01/28/2014 9:58:22 AM
273	$NVLX - Nuvilex Restructures to Focus on	stocklegend	01/28/2014 9:32:56 AM
272	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	01/28/2014 9:17:32 AM
271	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	01/28/2014 8:49:13 AM
270	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	01/27/2014 3:42:16 PM
269	$NVLX Nuvilex COO Talks About Companys	stocklegend	01/27/2014 3:20:19 PM
268	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	01/27/2014 3:06:46 PM
267	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	01/27/2014 2:40:30 PM
266	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	01/27/2014 2:18:40 PM
265	$NVLX Nuvilex Completes Acquisition of	stocklegend	01/27/2014 2:18:27 PM
264	$NVLX Nuvilex Accelerates Development of	stocklegend	01/27/2014 1:21:09 PM
263	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	01/27/2014 12:56:23 PM
262	$NVLX Nuvilex Ahead of the Curve on	stocklegend	01/27/2014 12:39:03 PM
261	$NVLX Investors Confidently Back Nuvilex's	stocklegend	01/27/2014 12:14:16 PM
260	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	01/27/2014 11:47:21 AM
259	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	01/27/2014 11:07:24 AM
258	NVLX NEWS:	stocklegend	01/27/2014 10:27:33 AM
257	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	01/27/2014 9:40:44 AM
256	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	01/27/2014 9:33:37 AM
255	$NVLX Nuvilex Begins Making Moves at its	stocklegend	01/27/2014 9:07:22 AM
254	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	01/27/2014 8:49:13 AM
253	$NVLX breakout candles called $0.15 PYCKtradr	PoemStone	01/27/2014 7:48:33 AM
252	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	01/24/2014 11:52:22 AM
251	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	01/24/2014 11:48:44 AM
250	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	01/24/2014 10:19:25 AM
249	$NVLX - Nuvilex Restructures its Operations to	stocklegend	01/24/2014 9:53:57 AM
248	NVLX news:	stocklegend	01/24/2014 9:43:48 AM
247	$NVLX - Nuvilex Restructures to Focus on	stocklegend	01/24/2014 9:41:33 AM
246	$NVLX - Nuvilex Contracts with Inno Biologics to	stocklegend	01/24/2014 9:00:48 AM
245	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	01/24/2014 8:39:23 AM
244	$NVLX Nuvilex Completes Acquisition of	stocklegend	01/23/2014 3:45:02 PM
243	$NVLX Nuvilex Accelerates Development of	stocklegend	01/23/2014 3:07:25 PM
242	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	01/23/2014 2:17:36 PM

Newer

Older

Recent Articles

• Central Garden & Pet Reports Q4 Earnings: Key Insights Revealed
• Analyzing Woodward's Q4 Earnings and Future Outlook
• Blue Bird's Financial Performance in the Latest Earnings Report
• Central Garden & Pet Reports Strong Q4 Earnings Performance
• Central Garden & Pet's Strong Q4 Earnings Highlights
• Enanta Pharma's Earnings Report Highlights for Investors in 2024
• Woodward Reports Strong Q4 Earnings, Offers Positive Guidance Ahead
• Blue Bird's Fourth Quarter Earnings: Key Insights and Analysis
• Leslie's Performance in Q4: Key Insights and Future Prospects
• Exploring Central Garden & Pet's Recent Earnings Performance
• Insights into Enanta Pharma's Q4 Earnings Performance
• Blue Bird's Q4 Earnings Report Reveals Key Insights
• NHTSA Stands Firm on New Emergency Braking Rule for Vehicles
• Columbia Financial Appoints Matthew Smith as New COO
• Impact of Treasury Picks on Markets and Emerging Economies
• Market Reactions: Insights on Zoom, Agilent, HanesBrands, Kohl's
• Zoom Communications Enhances Forecast Following Strong Q3 Results
• Leadership Transition at Kohl's: Kingsbury's Departure Announced
• Tempest Therapeutics to Showcase Innovations at Key Conference
• Travere Therapeutics Announces Key Upcoming Investor Conferences
• Tesla Stock Faces Market Challenges Amid California Proposals
• Chegg Inc. Experience Stock Surge Following Debt Repurchase Deal
• Zoom Communications Turns a Profit with Impressive Q3 Earnings
• First Capital, Inc. Declares New Quarterly Dividend for Investors
• Columbia Financial Welcomes New COO Matthew Smith Amid Changes
• Universal Health Realty Income Trust Boosts Quarterly Dividend
• Amazon Strengthens AI Alliances with Major Investment in Anthropic
• Enanta Pharma's Q4 Earnings Exceed Expectations, Highlights Ahead
• Woodward's Q4 Earnings Highlights and Future Outlook for Investors
• Blue Bird's Q4 Earnings: Performance Review and Insights
• Central Garden & Pet: Analyzing Quarterly Earnings Results
• Central Garden & Pet Q4 Earnings Show Surprising Results
• Semtech's Q3 Earnings Report Shows Promising Growth
• LanzaTech Expands Board for Future Growth with Energy Expert
• Zimmer Biomet Secures FDA Approval for Innovative Knee Implant
• Remitly to Showcase Innovations at Upcoming TMT Summit
• Dana Incorporates Leadership Change Amid Strategic Transformation
• Lexicon Pharmaceuticals Announces Upcoming December Investor Events
• Gaming and Leisure Properties, Inc. Announces Q4 2024 Dividend
• NJR Clean Energy Ventures Finalizes $132.5 Million Solar Sale
• ORIC Pharmaceuticals Enhances Visibility at December Conferences
• LanzaTech Welcomes Thierry Pilenko to Board of Directors
• Ant Group's IPO Collapse: Alibaba's Regulatory Struggles and Settlement Impact
• EMP Metals Secures $3 Million Loan Agreement with Tembo
• Leslies Experiences Financial Challenges in Latest Earnings
• Dana Incorporates Strategic Changes to Boost Growth and Value
• Fluence Energy Delivers Impressive Q4 Results and Growth Insights
• StealthGas Reports Impressive Q3 Earnings Growth
• Analyzing PennantPark Floating Rate's Q4 Earnings Results
• Insights on Pennant Park Investment's Latest Earnings Report